A RETROSPECTIVE COST-EFFECTIVENESS ANALYSIS OF S-AMLODIPINE IN CHINA

Author(s)

Hu S¹, Zhang Y², He J¹, Du L¹
¹Shanghai Health Development Research Center, Shanghai, China, ²shanghai Institution of Technolocy, Shanghai, China

Presentation Documents

PCV14--strong-u-hu-s-u-sup-1-sup-strong-zhang-y-sup-2-sup-he-j-sup-1-sup-du-l-sup-1-sup-br-sup-1-sup-shanghai-health-development-research-center-shanghai-china-sup-2-sup-shanghai-institution-of-technolocy-shanghai-china

OBJECTIVES:

Conference/Value in Health Info

2014-09, ISPOR Asia Pacific 2014, Beijing, China

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PCV14

Topic

Clinical Outcomes

Topic Subcategory

Comparative Effectiveness or Efficacy

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic

Clinical Outcomes

Quick Links

About

Media Center

Exhibits & Sponsorships

Contact Us

Policies & Legal

AI Policy

Antitrust Compliance

Code of Ethics

Cookie Policy

Diversity Policy

Funding Statement

Legal Disclaimer

Privacy Policy

Terms and Conditions

Subscribe
Join ISPOR

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.
International Society for Pharmacoeconomics and Outcomes Research, Inc
Website Design & Development by Matrix Group

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×